DAM
PRAH

Deimos Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Deimos Asset Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-36,000
Closed -$1.5M – 52
2016
Q2 		$1.5M Buy
36,000
+1,000
+3% +$46.1K 0.66% 31
2016
Q1 		$1.5M Buy
+35,000
New +$1.48M 1.1% 28

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Deimos Asset Management's PRAH Position: Q3 2016 in Review

Deimos Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2016, closing a stake of 36,000 shares — an estimated $1.5M sold.

Deimos Asset Management first reported a position in PRAH in Q1 2016 and held it in 2 quarters. The position peaked at $1.5M in Q2 2016. 172 funds tracked by Wall St. Rank hold PRAH as of Q3 2016.

  • Deimos Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2016 after selling out during the quarter.
  • Deimos Asset Management sold 36,000 PRA Health Sciences, Inc. shares in Q3 2016, an estimated $1.5M.
  • Deimos Asset Management first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 2 quarters.
  • Deimos Asset Management's PRA Health Sciences, Inc. position peaked at $1.5M in Q2 2016.
  • 172 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2016.

Based on Deimos Asset Management's 13F filing for Q3 2016.